Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Novartis
Novartis
Page 2 of 4
Leadership
Novartis CEO: It’s Time to “Pivot Towards Transformational Innovation”
By
Senior Editor
March 20, 2019
Net Drug Prices Are Falling, Even as List Prices Increase
By
Research Team
January 30, 2019
Canadian Pot Firm Tilray Goes Global With Novartis Marijuana Deal
By
Contributing Writer
December 18, 2018
Health
Why Cancer Biotech Allogene Just Scored an Eye Popping $324 Million IPO
By
Research Team
October 11, 2018
Health
Drug Giant Novartis Is Temporarily Backing Off Price Increases Following Trump Pressure
By
Contributing Writer
July 19, 2018
Health
Novartis Is Spinning Off Its Alcon Eye Care Business and Launching a $5 Billion Share Buyback
By
Senior Editor
June 29, 2018
Health
The FDA Approved a Promising New Drug to Treat Migraines. Now, the Drugmakers’ Stock Prices Are Rising
By
Blockchain Reporter
May 18, 2018
Health
The FDA Is Naming and Shaming Companies Accused of Blocking Cheap Generic Drugs
By
Investment Desk
May 17, 2018
Leadership
Top Novartis Lawyer Exits Over the $1.2 Million It Paid to Trump Lawyer Michael Cohen
By
Blockchain Reporter
May 16, 2018
Health
That $1.2 Million Payment to Trump’s Lawyer Wasn’t Even a Drop in the Bucket for Novartis
By
Industry Analyst
May 10, 2018
Health
Novartis Put Money In Michael Cohen’s Cookie Jar. Did It Get Any Cookies In Return?
By
Digital Assets Editor
May 9, 2018
Health
Why Analysts Are Calling Celgene’s $9 Billion Juno Acquisition a ‘Smart’ Biotech Deal
By
Editorial Team
January 22, 2018
Health
The First FDA-Approved Gene Therapy Can Cure a Type of Blindness—But May Cost $1 Million
By
Blockchain Reporter
December 19, 2017
Health
Gene Therapy Is Revolutionary Science That Can Cure Blindness. Is It Worth $1 Million a Pop?
By
Trading Desk
November 16, 2017
Health
We’ve Had Terrible Luck Trying to Cure Alzheimer’s. But What If We Could Prevent It?
By
Staff Writer
November 2, 2017
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Industry Analyst
Big Tech
Nvidia CEO says the company is in a no-win situation amid AI-bubble chatter, leaked meeting reveals
By
Industry Analyst
Travel & Leisure
Transportation chief offers advice to increasingly angry Americans: ‘Let’s maybe go back to an era where we didn’t wear...
By
Editorial Team